Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports,buying,selling,purchases Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Intellia Therapeutics Inc. (NTLA)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
NTLA Insider Trading Transactions for Intellia Therapeutics  Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-06-19
Sale
2018-06-20
12:03 pm
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
6,686 $27.96 $186,908 1,836,810
(Indirect)
View
2018-05-16
Sale
2018-05-17
10:47 am
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
6,686 $25.04 $167,389 2,058,299
(Indirect)
View
2018-05-14
Sale
2018-05-15
8:43 pm
Intellia Therapeutics Inc. NTLA LEONARD JOHN M.
CEO
8,400 $24 $201,600 467,352
(Direct
Indirect)
View
2018-03-20
Sale
2018-03-22
1:43 pm
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
39,245 $23.87 $936,743 2,279,788
(Indirect)
View
2018-01-29
Sale
2018-01-30
5:28 pm
Intellia Therapeutics Inc. NTLA Caribou Biosciences Inc.
10% Owner
550,645 $26.78 $14,746,273 3,994,355
(Indirect)
View
2017-12-12
Sale
2017-12-14
12:19 pm
Intellia Therapeutics Inc. NTLA Novartis Institutes for BioMedical Research Inc.
NOVARTIS AG
10% Owner
1,523,000 $18.3 $27,870,899 4,129,903
(Direct)
View
2017-12-06
Sale
2017-12-08
5:27 pm
Intellia Therapeutics Inc. NTLA Bermingham Nessan
CEO
336,783 $20.78 $7,000,019 696,000
(Direct)
View
2017-09-13
Sale
2017-09-13
6:29 pm
Intellia Therapeutics Inc. NTLA Caribou Biosciences Inc.
10% Owner
1,048,846 $0 $0 4,545,000
(Indirect)
View
2017-07-07
Sale
2017-07-11
5:40 pm
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
150,000 $16.24 $2,435,440 3,699,788
(Indirect)
View
2017-07-07
Sale
2017-07-11
5:37 pm
Intellia Therapeutics Inc. NTLA Atlas Venture Fund IX L.P.
Atlas Venture Associates IX L.P.
Atlas Venture Associates IX LLC
10% Owner
150,000 $16.24 $2,435,440 3,699,788
(Direct)
View
2017-03-09
Sale
2017-03-13
10:39 am
Intellia Therapeutics Inc. NTLA Atlas Venture Associates IX L.P.
Atlas Venture Associates IX LLC
10% Owner
21,132 $13.91 $293,843 3,729,788
(Indirect
Direct)
View
2017-03-09
Sale
2017-03-13
10:34 am
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
21,132 $13.91 $293,843 3,729,788
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2018-05-17
Option Award
2018-05-21
12:59 pm
N/A
2028-05-16
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
19,000 $25.98 19,000
(Direct)
View
2018-05-17
Option Award
2018-05-21
12:56 pm
N/A
2028-05-16
Intellia Therapeutics Inc. NTLA KARSEN PERRY A
Director
19,000 $25.98 19,000
(Direct)
View
2018-05-17
Option Award
2018-05-21
12:54 pm
N/A
2028-05-16
Intellia Therapeutics Inc. NTLA DORSA CAROLINE
Director
19,000 $25.98 19,000
(Direct)
View
2018-05-17
Option Award
2018-05-21
12:51 pm
N/A
2028-05-16
Intellia Therapeutics Inc. NTLA Verwiel Frank
Director
19,000 $25.98 19,000
(Direct)
View
2018-05-01
Option Award
2018-05-02
4:35 pm
N/A
2028-04-30
Intellia Therapeutics Inc. NTLA SCHIERMEIER ANDREW
VP
23,500 $20.56 23,500
(Direct)
View
2018-03-28
Exercise
2018-03-30
10:20 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Bell Graeme
CFO
8,000 $13.48 202,000
(Direct)
View
2018-03-28
Exercise
2018-03-30
10:20 am
N/A
2027-01-02
Intellia Therapeutics Inc. NTLA Bell Graeme
CFO
8,000 $13.48 202,000
(Direct)
View
2018-03-23
Option Award
2018-03-26
5:12 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA DORSA CAROLINE
Director
410 $24.05 5,410
(Direct)
View
2018-01-25
Option Award
2018-01-29
3:32 pm
N/A
2028-01-24
Intellia Therapeutics Inc. NTLA LEONARD JOHN M.
CEO
220,000 $22.78 220,000
(Direct)
View
2018-01-25
Option Award
2018-01-29
3:31 pm
N/A
2028-01-24
Intellia Therapeutics Inc. NTLA Bell Graeme
CFO
25,000 $22.78 25,000
(Direct)
View
2018-01-25
Option Award
2018-01-29
3:30 pm
N/A
2028-01-24
Intellia Therapeutics Inc. NTLA Rivera Jose E
VP
25,000 $22.78 25,000
(Direct)
View
2017-12-12
Option Award
2017-12-14
4:08 pm
N/A
2027-12-11
Intellia Therapeutics Inc. NTLA Rivera Jose E
VP
72,500 $18.3 72,500
(Direct)
View
2017-12-12
Option Award
2017-12-14
4:08 pm
N/A
2027-12-11
Intellia Therapeutics Inc. NTLA LEONARD JOHN M.
VP
72,500 $18.3 72,500
(Direct)
View
2017-12-12
Option Award
2017-12-14
4:07 pm
N/A
2027-12-11
Intellia Therapeutics Inc. NTLA Bermingham Nessan
CEO
292,500 $18.3 292,500
(Direct)
View
2017-12-12
Option Award
2017-12-14
4:06 pm
N/A
2027-12-11
Intellia Therapeutics Inc. NTLA Bell Graeme
CFO
72,500 $18.3 72,500
(Direct)
View
2017-11-03
Option Award
2017-11-03
11:54 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Bell Graeme
CFO
5,000 $22.04 13,400
(Direct)
View
2017-07-25
Option Award
2017-07-25
4:49 pm
N/A
2027-07-24
Intellia Therapeutics Inc. NTLA Verwiel Frank
Director
38,000 $16.91 38,000
(Direct)
View
2017-07-25
Option Award
2017-07-25
4:47 pm
N/A
2027-07-24
Intellia Therapeutics Inc. NTLA Slaoui Moncef
Director
38,000 $16.91 38,000
(Direct)
View
2016-06-02
Option Award
2017-06-05
08:03 am
N/A
N/A
Intellia Therapeutics Inc. NTLA DORSA CAROLINE
Director
5,000 $12.42 5,000
(Direct)
View
2017-06-01
Option Award
2017-06-05
08:01 am
N/A
N/A
Intellia Therapeutics Inc. NTLA KARSEN PERRY A
Director
5,000 $11.98 5,000
(Direct)
View
2017-06-02
Option Award
2017-06-05
07:59 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Bell Graeme
CFO
8,400 $12.37 8,400
(Direct)
View
2017-06-01
Option Award
2017-06-05
07:57 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Rivera Jose E
VP
8,400 $12.03 262,210
(Direct)
View
2017-06-01
Option Award
2017-06-05
07:55 am
N/A
N/A
Intellia Therapeutics Inc. NTLA LEONARD JOHN M.
VP
7,800 $12.06 466,408
(Indirect)
View
2017-06-01
Option Award
2017-06-05
07:55 am
N/A
N/A
Intellia Therapeutics Inc. NTLA LEONARD JOHN M.
VP
600 $12.09 466,408
(Indirect)
View
2017-06-01
Option Award
2017-06-05
07:53 am
N/A
N/A
Intellia Therapeutics Inc. NTLA Bermingham Nessan
CEO
8,400 $11.95 795,033
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:14 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA DORSA CAROLINE
Director
19,000 $14.35 19,000
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:12 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA FORMELA JEAN FRANCOIS
Director
19,000 $14.35 19,000
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:10 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA GORDON CARL L
Director
19,000 $14.35 19,000
(Direct)
View
2017-05-18
Option Award
2017-05-19
5:08 pm
N/A
2027-05-17
Intellia Therapeutics Inc. NTLA KARSEN PERRY A
Director
19,000 $14.35 19,000
(Direct)
View
2017-03-03
Other
2017-03-07
3:11 pm
N/A
N/A
Intellia Therapeutics Inc. NTLA Novartis Institutes for BioMedical Research Inc.
NOVARTIS AG
10% Owner
79,245 $0 5,652,903
(Direct)
View
Goto page 0, 1, Next